Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$191.17 - $325.63 $28,675 - $48,844
-150 Reduced 7.43%
1,868 $608,000
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $1,770 - $2,372
-11 Reduced 0.54%
2,018 $384,000
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $31,092 - $45,435
-160 Reduced 7.31%
2,029 $403,000
Q2 2023

Aug 10, 2023

SELL
$223.05 - $302.68 $943,947 - $1.28 Million
-4,232 Reduced 65.91%
2,189 $624,000
Q1 2023

May 11, 2023

SELL
$175.41 - $217.92 $163,832 - $203,537
-934 Reduced 12.7%
6,421 $1.39 Million
Q4 2022

Feb 02, 2023

BUY
$204.38 - $296.82 $182,920 - $265,653
895 Added 13.85%
7,355 $1.51 Million
Q3 2022

Nov 04, 2022

SELL
$195.21 - $310.53 $18,154 - $28,879
-93 Reduced 1.42%
6,460 $1.8 Million
Q2 2022

Aug 01, 2022

SELL
$115.91 - $214.48 $67,343 - $124,612
-581 Reduced 8.14%
6,553 $1.25 Million
Q1 2022

May 10, 2022

SELL
$127.96 - $207.36 $143,443 - $232,450
-1,121 Reduced 13.58%
7,134 $1.48 Million
Q4 2021

Feb 08, 2022

BUY
$165.13 - $241.83 $511,407 - $748,947
3,097 Added 60.04%
8,255 $1.47 Million
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $589,872 - $847,345
-3,597 Reduced 41.09%
5,158 $1.06 Million
Q2 2021

Aug 13, 2021

BUY
$131.45 - $201.49 $151,430 - $232,116
1,152 Added 15.15%
8,755 $1.66 Million
Q1 2021

May 14, 2021

BUY
$92.73 - $142.05 $120,734 - $184,949
1,302 Added 20.66%
7,603 $990,000
Q4 2020

Feb 09, 2021

BUY
$67.44 - $103.72 $189,978 - $292,179
2,817 Added 80.86%
6,301 $654,000
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $149,080 - $264,087
3,484 New
3,484 $264,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.